Yiting Wang, Pei Wang, Qi Wang, Shitong Chen, Xiaofei Wang, Xiaobo Zhong, Wanglai Hu, Rick F Thorne, Shengna Han, Mian Wu, Lirong Zhang
Biochemical pharmacology 2024 FebCytochrome P450 3A4 (CYP3A4) is the most important and abundant drug-metabolizing enzyme in the human liver. Inter-individual differences in the expression and activity of CYP3A4 affect clinical and precision medicine. Increasing evidence indicates that long noncoding RNAs (lncRNAs) play crucial roles in the regulation of CYP3A4 expression. Here, we showed that lncRNA hepatocyte nuclear factor 1 alpha-antisense 1 (HNF1A-AS1) exerted dual functions in regulating CYP3A4 expression in Huh7 and HepG2 cells. Mechanistically, HNF1A-AS1 served as an RNA scaffold to interact with both protein arginine methyltransferase 1 and pregnane X receptor (PXR), thereby facilitating their protein interactions and resulting in the transactivation of PXR and transcriptional alteration of CYP3A4 via histone modifications. Furthermore, HNF1A-AS1 bound to the HNF1A protein, a liver-specific transcription factor, thereby blocking its interaction with the E3 ubiquitin ligase tripartite motif containing 25, ultimately preventing HNF1A ubiquitination and protein degradation, further regulating the expression of CYP3A4. In summary, these results reveal the novel functions of HNF1A-AS1 as the transcriptional and post-translational regulator of CYP3A4; thus, HNF1A-AS1 may serve as a new indicator for establishing or predicting individual differences in CYP3A4 expression. Copyright © 2023 Elsevier Inc. All rights reserved.
Yiting Wang, Pei Wang, Qi Wang, Shitong Chen, Xiaofei Wang, Xiaobo Zhong, Wanglai Hu, Rick F Thorne, Shengna Han, Mian Wu, Lirong Zhang. The long noncoding RNA HNF1A-AS1 with dual functions in the regulation of cytochrome P450 3A4. Biochemical pharmacology. 2024 Feb;220:116016
PMID: 38176619
View Full Text